Literature DB >> 87797

Use of prostacyclin in persistent fetal circulation.

J E Lock, P M Olley, F Coceani, P R Swyer, R D Rowe.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 87797     DOI: 10.1016/s0140-6736(79)91970-6

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  8 in total

Review 1.  Nobel lecture, 8th December 1982. Adventures and excursions in bioassay: the stepping stones to prostacyclin.

Authors:  J R Vane
Journal:  Br J Pharmacol       Date:  1983-08       Impact factor: 8.739

Review 2.  Nobel lecture. Adventures and excursions in bioassay--the stepping stones to prostacyclin.

Authors:  J R Vane
Journal:  Postgrad Med J       Date:  1983-12       Impact factor: 2.401

Review 3.  Eighth Gaddum Memorial Lecture. University of London Institute of Education, December 1980. Biological importance of prostacyclin.

Authors:  S Moncada
Journal:  Br J Pharmacol       Date:  1982-05       Impact factor: 8.739

4.  Side effects occurring during administration of epoprostenol (prostacyclin, PGI2), in man.

Authors:  H Pickles; J O'Grady
Journal:  Br J Clin Pharmacol       Date:  1982-08       Impact factor: 4.335

5.  Comparison between prostaglandin E1 and epoprostenol (prostacyclin) in infants after heart surgery.

Authors:  J Kermode; W Butt; F Shann
Journal:  Br Heart J       Date:  1991-08

6.  Haemodynamic effects of prostacyclin (PGI2) in pulmonary hypertension.

Authors:  D N Guadagni; H Ikram; A H Maslowski
Journal:  Br Heart J       Date:  1981-04

7.  Prostaglandins, ductus arteriosus, pulmonary circulation: current concepts and clinical potential.

Authors:  F Coceani; P M Olley; J E Lock
Journal:  Eur J Clin Pharmacol       Date:  1980-07       Impact factor: 2.953

Review 8.  Prostanoid therapies in the management of pulmonary arterial hypertension.

Authors:  Barbara L LeVarge
Journal:  Ther Clin Risk Manag       Date:  2015-03-31       Impact factor: 2.423

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.